Medpace
MEDP
$395.93
Share price
1.58%
Change (1 day)
100.43%
Change (1 year)
Categories
P/S ratio for Medpace (MEDP)
P/S ratio as of April 2024 (TTM): 6.49
According to Medpace's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.488. At the end of 2023 the company had a P/S ratio of 4.99.
P/S ratio history for Medpace from 2016 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.99 | 10.23% |
| 2022 | 4.52 | -33.92% |
| 2021 | 6.85 | 27.32% |
| 2020 | 5.38 | 52.73% |
| 2019 | 3.52 | 31.42% |
| 2018 | 2.68 | -9.04% |
| 2017 | 2.95 | -15.46% |
| 2016 | 3.48 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |